Leptin, the protein product of the ob gene, is mainly synthesized in adipose cells. In humans, leptin is also expressed in the placenta, which represents an important site of production contributing to enhanced leptinemia in pregnant women. Recent observations suggest that ob gene expression and leptin production are up-regulated in pathological pregnancies associated with diabetes or preeclampsia. In agreement with previous observations at the mRNA level (Mise et al., 1998, J Clin Endocrinol Metab 83:3225-3229) , we show here that leptin protein content was increased 6-fold (p`0.01, n 12) in preeclamptic placentas. Since this disorder is associated with placental hypoxia, this prompted us to test the hypothesis that hypoxia is a regulatory factor of leptin gene expression.
The effect of hypoxia was assessed in leptin-producing trophoblastderived cells (BeWo). After reaching 70% con¯uence, cells were exposed for 24 hrs to normoxic (20% oxygen) or hypoxic conditions (6% oxygen, 50 mM Cobalt chloride (Co) or 50 mM desferrioxamine (DFO)). Chemical hypoxia induced by Co or DFO increased leptin release by 2 fold in these cells. The activity of 5'-¯anking sequences of human leptin gene upstream of the luciferase reporter gene was also examined in transiently transfected BeWo cells. Using deletion constructs of different length, we were able to map two hypoxia-responsive regions. The ®rst 1.20 kb of the promoter were responsible for low hypoxia responsiveness (2 to 3-fold effect), while one region [72.38 to 71.20 kb] conferred high responsiveness to hypoxia (4 to 10-fold effect). This effect was independent of the presence of the Placental Leptin Enhancer (PLE) previously described in the [72.38 to 71.20 kb] domain.
In contrast, Co or DFO did not enhance luciferase promoter driven activity in adipose cells (primary rat adipose cells and 3T3-L 1 cells), suggesting that placenta-speci®c transacting factors are involved in the regulation.
These data demonstrate for the ®rst time that hypoxia is a potent transcriptional inducer of leptin gene expression in placental cells. This may account for increased placental leptin production in preeclampsia.
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High fat diet, vitamin A supplementation and retinoic acid induce uncoupling protein 3 expression in mouse muscle Previous results indicated that vitamin A, as retinoic acid (RA), affects rodent energy balance through changes in brown adipose tissue (BAT) thermogenesis. Acute RA-treatment triggered an increment of BAT thermogenic capacity, in terms of uncoupling protein 1 (UCP1) expression that correlated with a reduction of adiposity and body weight. Skeletal muscle may have a key contribution to whole body thermogenesis, and a UCP1 homologue, UCP3, is primarily expressed both in BAT and skeletal muscle of rodents. We wanted to evaluate the impact of chronic vitamin A supplementation on muscle UCP3 expression and on the development of diet-induced obesity. Four experimental groups of C57BLa6J mice were used: mice fed a normal fat or a high fat diet (10% or 45% of energy as fat), with either a normal vitamin A content or supplemented with vitamin A (1.97 or 77 mg retinol palmitatea1000 kcal). The diets were given from week 4 of age for a period of 18 weeks. The high fat diet led to an excess of body weight and adiposity that was not signi®cantly affected by vitamin A supplementation, although body weight gain and subcutaneous fat mass tended to be lower in the high vitamin A-high fat diet fed animals than in normal vitamin A-high fat diet fed animals. Skeletal muscle UCP3 mRNA levels increased after both high fat diet and vitamin A supplementation, but the effect of the two dietary conditions was not cumulative. BAT UCP3 mRNA levels increased in response to high fat diet, but not vitamin A supplementation, while changes of BAT UCP1 were similar to those of muscle UCP3. In a second experiment, the effects of acute RAtreatment were evaluated using NMRI mice subcutaneously injected either RA (100 mgakg) or vehicle (olive oil) during the four days before they were killed. The treatment led to a signi®cant increment of UCP3 mRNA levels in skeletal muscle, but not in BAT.
We conclude that skeletal muscle UCP3 expression responds to dietary conditions, and that there are differences between BAT and skeletal muscle concerning the regulation of UCP3 expression by retinoids.
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In¯uence of family history for type 2 diabetes on fuel metabolism in overweight and obese patients P31 Depot-speci®c adipose tissue expression of sterol response element binding protein 1c expression in obese subjects before and after weight loss Sterol response element binding proteins (SREBP) are transcription factors that have been associated with lipogenesis, adipogenesis and cholesterol homeostasis. SREBP-1c is the major isoform of SREBPs expressed in human white adipose tissue. We studied the expression of SREBP-1c before and after weight loss in different adipose tissue depots in obese subjects. 35 massively obese subjects (12 men, 23 women) participated in the study (age 44 AE 10 y, weight 146 AE 30 kg, % of body fat 42 AE 5, mean AE SD). Adipose tissue biopsies were taken from omental (OM), subcutaneous abdominal (AS) and subcutaneous femoral (FS) depots before weight loss. After one year of weight loss biopsies were taken from AS and FS. Subcutaneous samples were also taken from 6 normal weight subjects. SREBP-1c mRNA levels were determined by RT-competitive PCR.
The SREBP-1c levels were 3.8 AE 1.8 amolamg of total RNA for AS, 4.0 AE 1.9 for FS and 1.8 AE 1.0 for OM before weight loss. The level of SREBP-1c mRNA was signi®cantly lower in the OM region (p`0.01) than in AS or FS. There were no differences between genders. The values in AS and FS were about 2-time lower in obese than in normal weight subjects (7.4 AE 2.5 for AS and 6.5 AE 1.5 for FS, p`0.01). After one year of weight loss the mRNA levels of SREBP-1c increased in AS (5.1 AE 2.2, p`0.01) and in FS (4.8 AE 2.7, ns).
In summary, SREBP-1c mRNA expression was lower in the OM with respect to the subcutaneous depots in obese subjects before weight loss. Furthermore, the expression of SREBP-1c in subcutaneous fat was signi®cantly reduced in obese compared to normal weight subjects. After one year of weight loss SREBP-1c mRNA levels increased in the subcutaneous adipose tissues of obese subjects. Regulation of SREBP-1c expression in adipose tissue may thus play a role in the metabolic changes related to weight loss in human obesity.
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Prevalence of overweight and obesity among 6 to 16 year old German children using BMI and weight for height de®nitions Using weight for height data 6% of the boys and 7% of the girls were obese in 1982, whereas in 1998a1999 9% of the boys and 7% of the girls are obese. CONCLUSION: According to the French BMI percentiles 14% of German boys and 12% of German girls are obese. These high ®gures may be ± at least as a part ± an acceleration phenomenon because German children in 1998a1999 were at a given age taller and heavier than French children more than 10 years ago. Using age independent weight for height data the prevalence of obesity is lower. Nevertheless overweight and obesity are serious health problems among German children.
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Early life and inter-generational factors on waist circumference in young adults (1972 ± 9) . METHODS: Children who participated in the Growth Study (n 951) were followed up at age 25 ± 26. Detailed anthropometric measurements were available for all subjects from birth to age 5, and on their mothers during pregnancy. 678 (71%) young adults attended a clinic where anthropometric measurements were made and details collected of their current behaviours and social class. Their middle aged parents were mailed a questionnaire and asked to record their height, weight and waist circumference and provide information on their current lifestyle and social class. 435 (69%) mothers and 332 (55%) fathers responded. Parent and offspring variables were assessed in multivariable models to determine factors associated with waist circumference at age 25 ± 26. To ascertain associations with fat distribution rather than adiposity per se, all models included BMI at age 25 ± 26. RESULTS: Size at birth was inversely associated with waist circumference in young adulthood. Per unit increase in z score for ponderal index at birth was associated with a waist circumference 0.66 cm (95% CI 71.09, 70.24) lower in males and 0.47 cm (95% CI 70.94, 0.00) lower in females. The highest waist circumferences tended to be found in males who were thin at birth but had a high BMI at age 5. This was despite the fact that a lower BMI at age 5 also predicted a higher waist circumference at age 25 ± 26 in males (70.78, 95% CI 71.21, 70.36) . Social class group ± in childhood or adulthood ± did not attenuate these associations and had only a weak in¯uence on offspring waist circumference. In males, this was also true of maternal BMI during pregnancy, and parental BMI or waist circumference in middle age. Exercise frequency at age 25 ± 26 did slightly attenuate the observed association between PI at birth and later waist circumference in males. In females, the association with size at birth was attenuated, becoming non signi®cant, in multivariable analyses with maternal weight gain during pregnancy and BMI in middle age. Females who had given birth or were older at menarche had a higher waist circumference than their peers. CONCLUSION: Adiposity in early life may in¯uence body fat distribution in adulthood.
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The effect of Bardet-Biedl Syndrome on the components of energy balance intake may be more aetiologically important in BBS-related obesity than those associated with energy intake may be more aetiologically important in BBSrelated obesity than those associated with energy expenditure. The presence and nature of hyperphagia in BBS merits further investigation.
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P35
The in¯uence of fetal growth on BMI, waist circumference and body fat in adult twins Low birth weight has been associated with several adult onset diseases and also with abdominal obesity. Twins share genes and early environment but often differ in birth weight. A twin study provides an opportunity to study the effect of birth weight differences on indicators that can lead to obesity in later life. The aim of the study was to assess whether body mass index (BMI), waist circumference (WC) and body fat differ in heavier and lighter twins of pairs with different birth weight. 130 same sex twin pairs who were born in Aberdeen were traced through the Aberdeen Maternity and Neonatal Databank which provides information on birth weight. 52 pairs were male and 78 pairs were female, with a mean age of 32.8 (range 18 ± 50) years. Body fat was measured by using the Bodystat 1500 bio-impedance analyser. Zygosity was determined by DNA ®ngerprinting.
In 14 twin pairs birth weight was identical: in the remaining 116 pairs the mean birth weight was 2,665 (range 907 ± 3954) g in the heavier twin and 2,289 (range 870 ± 3175) g in the lighter twin. The INTRODUCTION: Differences in the prevalence of obesity are seen between countries as well as within countries, but the reasons for the differences are poorly understood. In several studies, a higher prevalence of obesity is found in the more sparsely compared to the more densely populated areas, especially the metropolitan areas. The aim of this study is to search for possible determinants of these regional differences among young Danish men.
METHODS:
The study population comprises the men registered for military service during the period 1966 to 1977 in the greater Copenhagen area (region 1), and in the remaining provincial part of Zealand and adjoining islands (region 2). All men with a BMI ! 31 kgam 2 were identi®ed and classi®ed into an obese group (n 1342). As a control group, a 1% random sample from the study population was drawn (n 1606). Data on age at examination, weight, height, IQ test score, educational attainment and place of birth were available for logistic regression analyses. RESULTS: The crude odds ratio (only adjusted for year of examination), for being obese in region 2 compared to region 1 was 1.74 (CI 1.50 ± 2.02). Age at examination, IQ test score and educational level were all highly signi®cantly associated with odds ratio for obesity. After adjusting for these parameters, odds ratio was reduced to 1.54 (CI 1.31 ± 1.81). Additional adjustments for birth place in either region 1, 2, or in the remaining part of Denmark, reduced the odds ratio to 1.45 (CI 1.13 ± 1.86). Further analyses of the importance of birth place are in progress. CONCLUSION: Despite high degree of socioeconomic and cultural homogeneity and short geographical distances, the risk of being obese among young men from the neighbouring more sparsely populated areas was 45% higher than among young men from the greater Copenhagen areas. Adjustment for educational level and IQ score, which are well known factors negatively related to both obesity and to population density, could explain only a small part of the differences between the two regions. Place of birth may play a greater role in explaining current regional differences in obesity, which requires further inquiry.
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The impact of PPARg2-Pro12Ala variation on common metabolic disorders 
KS
INTRODUCTION:
To investigate the impact of the peroxisome proliferatoractivated receptor(PPAR)g2 variation-Pro 12Ala on body adipose tissue content and distribution, insulin secretion and its action, as well as adult common metabolic disorders. METHODS: In 340 Chinese subjects, including 184 non-diabetics and 156 type 2 diabetics, PPARg2-Pro12Ala variation was detected by a mismatched downstream PCR primer with introducing a Bst U-I restriction site in PPARg2-Ala 12 allele. RESULTS: (1). The frequencies of the Ala12 carrier (the subjects with the genotype of ProaAla and AlaaAla) and the Ala12 allele in Chinese population were 0.04 and 0.02, respectively, which were signi®cantly lower than those in Caucasians (Fisher two-side exact test, P value was 0.005 and 0.006, respectively); (2). PPARg2-Pro12Ala variation was associated with body adipose tissue content. The frequencies of the Ala12 carrier and the Ala12 allele were signi®cantly higher in BMI ! 25 subgroup than those in BMI`25 subgroup (Fisher exact test, P value was 0.034 and 0.025, respectively); (3). In nondiabetic subjects, PPARg2-Pro12Ala was associated with abdominal subcutaneous adipose tissue content. The frequency of Ala12 carrier was signi®cantly higher in subjects with higher abdominal subcutaneous adipose tissue cross section area (SA) subgroup than that in lower SA subgroup (Fisher exact test, P 0.045). The SA level in Ala12 carrier subgroup was higher than that in nonAla12 carrier subgroup (P 0.006). Stepwise regression analysis showed that PPARg2-Pro12Ala was an independent contributing factor for SA (P 0.012); (4). PPARg2-Pro12Ala was not related to blood glucose, lipid pro®le, blood pressure, and insulin secretion and its action in non-diabetics. Moreover, this variation was not associated with diabetes. CONCLUSION: PPARg2-Pro12Ala variation is one of the contributing factors for the etiologically inter-related adult common metabolic disorders. Its contribution is through the effect on the body adipose tissue, especially the abdominal subcutaneous adipose tissue depots.
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Up-regulation of UCP-2 expression by fatty acids in cultured human mucle cells In vivo data suggested that fatty acids (FA) up-regulate uncoupling proteins (UCPs) expression in skeletal muscle. Our aim was to identify the mechanisms by which poly-unsaturated FA increase UCP-2 expression. METHODS: Differentiated human muscle cells in primary culture were incubated with FA and UCP2 mRNA levels were determined by RT competitive-PCR. RESULTS: o-6 FA and arachidonic acid induced a 3 fold rise in UCP-2 mRNA levels likely through transcriptional activation. This effect was prevented by indomethacin and mimicked by PGE2 and cPGI2, consistent with a cyclooxygenase mediated process. Incubation of myotubes for 6 h with 100 mM arachidonic acid resulted in a 150-fold increase in PGE2 and a 15-fold increase in PGI2 in the culture medium. Consistent with a role of cAMP and protein kinase A, both prostaglandins induced a marked accumulation of cAMP in human myotubes, and forskolin reproduced the effect of arachidonic acid on UCP-2 mRNA expression. Inhibition of protein kinase A with H-89 suppressed the effect of PGE2 while cPGI2 and arachidonic acid were still able to increase UCP-2 gene expression, suggesting additional mechanisms. We found, however, that the MAPkinase pathway was not involved. On another hand, a speci®c agonist of PPARb (L165041) increased UCP-2 mRNA levels whereas activation of PPARa or PPARg was ineffective. CONCLUSION: These results suggest that UCP-2 gene expression is regulated by o-6 fatty acids in human muscle cells through mechanisms involving at least protein kinase A and the nuclear receptor PPARb.
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Leptin receptor gene (LEPR) polymorphisms are associated with substrate oxidation after a glucose load 
INTRODUCTION:
Resting energy expenditure is mainly determined by fat free mass, and additionally by age, gender, hormones and possibly also by genetic differences among people. A relation between the hormone leptin and resting metabolic rate was found in some, though not all, previous studies. METHODS: We evaluated whether LEPR gene polymorphisms were associated with energy expenditure phenotypes. RMR and RQ were measured in 192 women, aged 18 ± 60, BMI b 20. In 103 subjects, for whom urinary nitrogen excretion data were available, fat, protein and carbohydrate oxidation were calculated. In 38 subjects this was followed by a measurement of energy expenditure after a 75 g oral glucose load during 3 h (GIT). Three LEPRpolymorphisms were typed on genomic DNA: LyslO9Arg, Gln223Arg and Lys656Asn. RESULTS: Mean age was 40 AE 10 yrs, mean BMI 37.6 AE 6.4 kgam 2 . No differences in weight, BMI or fat mass were found across the different genotypes. Mean RMR was 1660 kcala24 h, and it increased by 11% after the glucose load. Mean fasting RQ was 0.83, rising to 0.88 during GIT. No associations were found between these measures of energy expenditure and the 3 LEPRpolymorphisms. However, differences were found with substrate oxidation for the Lys656Asn polymorphism. In fasting conditions, Lys656Lys homozygotes showed a trend to oxidize about 5% more carbohydrates (p 0.11) and less fat (p 0.12) than Asn656 carriers. This became signi®cant after the glucose load, when carbohydrate oxidation in Lys656Lys rose to 64.6 AE 4.4%, which was 15% higher than in Asn656 carriers (p 0. The metabolic syndrome is characterised by a cluster of disorders, type 2 diabetes, obesity, dyslipidaemia and hypertension, which are both genetically and environmentally determined. The present study was undertaken in order to describe the familiality of risk factors for the metabolic syndrome in 248 Danish Caucasian offspring of 60 unrelated type 2 diabetic patients. All offspring and 54 non-diabetic spouses were examined in the fasting state and underwent a tolbutamide-modi®ed frequently sampled intravenous glucose tolerance test (FSIGTT) with estimates of insulin sensitivity (Si), glucose effectiveness (Sg) and acute insulin response 0 ± 8 min (AIR) calculaled by minimal model analysis. Familiality (h 2 ) of the examined traits was estimated using variance component analysis with adjustment for relavant covariates. UCP1, a speci®c brown adipose tissue (BAT) protein, is the major molecule involved in adaptive thermogenesis. UCP2 and UCP3 are two UCP1 homologues with a wider distribution pattern. UCP2 is expressed in white adipose tissue (WAT) and in a variety of other tissues, while UCP3 is expressed predominantly in BAT and in skeletal muscle. Unlike UCP1, the functions of the UCP1 homologues are currently unknown. UCP2 and UCP3 have been implicated in lipid utilisation, in the limitation of reactive oxygen species production or in immunity, but their possible relevance to body weight control has also been suggested.
In order to characterise UCPs' ontogenic pattern we have studied, by northern blotting, UCP1, UCP2 and UCP3 mRNA expression in BAT and in different WAT depots (epididymal, inguinal, mesenteric and retroperitoneal). The study was carried out using male rats of different ages, from the suckling period up to one year of age.
UCP1 and UCP3 gene expression patterns are similar with age in BAT and in the different WAT depots studied, with higher expression levels in suckling (18 days) and in mature adult rats (1 year), periods in which a higher amount of heat is required. This similarity would be in favour of a putative thermogenic role for UCP3, not only in BAT but also in WAT. Moreover, it could indicate that both genes share common regulatory mechanisms. The expression pattern of UCP2 (only detectable in WAT) is different, with a peak of expression at the age of 2 months when the levels of expression of the other proteins are low, thus suggesting a different regulation and probably a different role for UCP2, which is not apparently related with any extra-heat need. Leptin takes part of the regulatory system that regulates body weight. It has been proposed as an``adipostat'' to signal the state of body triglyceride stores to the brain for precise regulation of long-term energy balance. Some dietary manipulations, such as food restriction, fasting and carbohydrate intake appear to in¯uence leptin secretion. The aim of the present work was to investigate the effect of different lipid sources on ob gene expression and serum leptin levels in rats fed two different feeding protocols.
In experiment I forty rats (n 10agroup) were fed ad libitum diets which provided 40% of energy as fat for 4 weeks. In experiment II forty rats (n 10agroup) were fed the same diets used in experiment I in amounts that provided 300 kJaday. ob mRNA levels in adipose tissues were assessed by northern blot and fasting serum leptin concentrations by ELISA. This study was designed to whether polymorphisms in UCP-1 and b 3 -AR genes affect strict weight-loss treatment in obese Japanese women. The study group comprised 69 women with a BMI of 25 or more (mean, 30.0 AE 4.6).
The subjects received strict diet and exercise treatment including behavioral therapy, administered by physicians and nutritionists. After informed consent was obtained, polymorphisms in the UCP-1 and b 3 -AR genes were analyzed in DNA derived from a hair sample. Polymorphisms were detected by amplifying the DNA extract by means of PCR, followed by restrictionenzyme digestion. The extract was then evaluated by agarose electrophoresis.
The following polymorphisms were detected: b 3 -AR TT: UCP AA in 9 patients (13.0%), b 3 -AR TT: UCP AGaGG in 34 (49.3%), b 3 -AR ATaAA: UCP AA in 7 (10.1%), and b 3 -AR ATaAA: UCP AGaGG in 19 (27.5%). These results differ markedly from those in Caucasian. These four groups were compared with respect to body weight before weight loss, BMI, waist circumference, % fat, FFM, REE, VO 2 max, blood lipids, and HOMA index, but no signi®cance differences were found. After weight loss, body weight had decreased signi®cantly (7.1% to 10.0%) in all groups, and there were no differences between any groups. BMI, waist circumference, and %fat decreased signi®-cantly, and VO 2 max increased signi®cantly, but there were no differences in these variables among the groups.
Polymorphisms in UCP-1 and b 3 -AR genes in obese Japanese women differ from those in obese Caucasian women. These mutations do not in¯uence the outcome of strict weight loss therapy in Japanese women, suggesting that behavioral and environmental factors play a central role in obesity. Genes encoding the b 3 -adrenoreceptor (b 3 -AR) and the uncoupling protein 1 (UCP1) are involved in thermogenesis. Associations of these genes with obesity have been reported in various human populations. The aim of this study was to investigate the relationship between Trp64Arg b 3 -AR and 3826A?G UCP1 polymorphisms and obesity related anthropometrical and biochemical parameters in a sample of the Spanish population, as well as to determine if there is an additive effect of both polymorphisms. Anthropometrical measurements such as BMI, waist to hip ratio, and sagittal abdominal diameter were performed. Glucose, triglycerides, total and HDL-cholesterol, insulin, proinsulin and leptin levels were determined. Oral glucose tolerance test according to WHO Expert Committee criteria (1997) was also performed. Genotyping was performed by RFLP-PCR (restriction fragment length polymorphism-polymerase chain reaction) in agreement with protocols previously described. Statistical analysis included Student's t-test, ANOVA, and logistic regression analysis.
In the overall population (n 334, 48% men and 52% women) there were no differences in the Arg64 allele frequencies either according to sex or obesity (BMI ! 30). However, G allele frequency was higher in men than in women (0.31 vs 0.21, p 0.015) and, in women, it was higher in obese than in non-obese (0.31 vs 0.17, p 0.008). Among the associations obtained, we found a positive one between age and Arg64 allele in obese subjects and in women, both obese and non-obese. Besides, women carriers of Arg64 had lower levels of 2 h post-load glucose and, when they were obese, higher leptin levels than non-carriers. GG genotype was associated with lower values of HDL in the whole population and in non-obese subjects, and with higher leptin levels in women. AG genotype appeared associated with higher leptin levels in non-obese women but with lower leptin levels in non-obese men. When the combined effect of both alleles (Arg64 and G) was analysed, differences in leptin levels were found only when women carriers of the Arg64 allele but not of the G allele vs non-carriers were compared. Our results suggest that these polymorphisms could be related with some obesity-linked parameters. Moreover, we have found an association between leptin levels and Arg64 and G alleles, which would mainly be present in women.
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The in¯uence of a b 3 -adrenergic polymorphism on the risk of obesity is evident in young adults 
INTRODUCTION:
Obesity is thought to be partly in¯uenced by several genes. One of these candidate genes is the b 3 -adrenoceptor (b 3 -AR) gene. A missense mutation in codon 64 of the human b 3 -AR gene (Trp64Arg) has been studied in various populations related to obesity or weight gain. We assessed the association between (b 3 -AR) mutation and the risk of obesity in a case-control study. METHODS: The study population comprised 313 subjects, aged 20 ± 60, recruited from a Spanish population. Cases were 159 obese patients (BMI b 30 Kgam 2 ) and controls were 154 normal-weight subjects (BMI2 5 Kgam 2 ). b 3 -AR genotype was determined by PCR followed by enzymatic digestion with BstNI. The amount of leisure-time physical activity was quanti®ed by a validated questionnaire and assigning Metabolic Equivalents (METs) to each activity recorded. RESULTS: Prevalence of the mutation was 19.5% in cases vs. 16.2% in controls. We estimated the association between the risk of obesity and the Trp64Arg mutation with adjustment for gender, age and METs using multivariate logistic regression models. A statistically signi®cant interaction (p 0.035) between age and b 3 -AR mutation was found in this model. As the ®gure shows, the risk associated with the mutation was signi®cantly higher at younger ages.
CONCLUSION:
Our results suggest that young (20 ± 33 years old) carriers of the Trp64Arg mutation have an increased risk for developing obesity.
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High free fatty acid availability and gene expression in different rat fat depots and skeletal muscles Changes in the transcription pro®le of adipose tissue and skeletal muscle are poorly understood processes involved in the pathogenesis of obesity and insulin resistance. Circulating free fatty acid (NEFA) may play a relevant role (1) and explain the preferential channelling of excess calories as fat rather than protein or glycogen. The aim of the present study was to investigate fuel partitioning during exposure to high plasma NEFA levels by comparing the expression of different genes in white fat and skeletal muscle, and their relationship with overall and tissue glucose metabolism. Lean Zucker rats received three-and 24-h infusions of Intralipid plus heparin, or saline plus heparin. Glucose uptake was determined in various tissues at the end of the infusion period by means of the 2-deoxy- [1- 3 H]-D-glucose ([ 3 H]-2DG) technique after an euglycemic hyperinsulinemic clamp. Our results show that high NEFA levels markedly decreased the insulin-mediated glucose uptake in red ®ber-type muscles, and enhanced the glucose utilisation in visceral fat. This was paralleled by decrease ($25%) and increase ($45%) of GLUT4 mRNA levels in red ®ber-type muscle and in visceral adipose tissue, respectively. Furthermore, there were marked increases in FATaCD36, TNF-a, PPARg, leptin, UCP2 and UCP3 mRNA levels in the visceral fat and muscle of the treated animals in comparison with those measured in the saline-treated animals. These data suggest that the in vivo gene expression in visceral fat and red ®ber-type muscle are differently regulated by circulating lipids, and that selective insulin resistance seems to favour, at least in part, a prevention of fat accumulation in tissues not primarily destined for fat storage. Tissular remodelling in adipose tissue occurs during obesity. Since changes in the extracellular matrix (ECM) are associated with such process, we studied the expression in adipose tissue of the key enzymes involved in the modulation of ECM: the matrix metalloproteinases (MMPs). MMP activity (determined by gelatin zymography on media) and expression (by Western blot and RT-PCR analysis) were studied in human subcutaneous adipose tissue (hSCAT) and in 3T3F442A murine preadipocyte cell line. Adipocyte differentiation was evaluated by various speci®c markers (glycerol release, triglyceride accumulation, hormone-sensitive lipase expression).
MMP-2 and 79 activities were demonstrated in media from hSCAT maintained ex vivo for 24 h and MMP-2 and -9 transcripts were identi®ed in mature human adipocytes. Moreover, primary cultures of human preadipocytes con®rmed the adipocyte-derived production of MMPs. The further characterization performed on 3T3F442A preadipocytes demonstrated that MMP expression as well as activity in the media increased signi®cantly during adipocyte differentiation whereas the expression of tissue inhibitor metalloproteinases (TIMP) 71 and 72 were abolished or not affected, respectively. Finally, treatment of con¯uent murine preadipocytes with MMP-inhibitors such as captopril, as well as neutralizing antibodies against MMP-2 and -9, inhibited markedly the adipocyte differentiation.
These data suggest that modulation of the interactions between preadipocytes and ECM through the production of MMPs might be an important key regulator of adipocyte differentiation.
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Human UCP3 protein expression is increased by feeding a high-fat diet for seven days
MKC Hesselink
1 , E Hultman 1 , R Nieuwlaat 1 , E Kornips 1 , WHM Saris 1 , and P Schrauwen In rodents as well as in humans UCP3 gene expression can be increased by raising plasma free fatty acid levels (NEFAs) by fasting or feeding a high-fat diet. Recently, we showed in humans that 4-wk consumption of a high-fat diet increased UCP3 mRNA expression (1) . However, data on UCP3 protein expression in relation to dietary interventions in humans is lacking. Here we investigated the effect of a 1-week high-fat diet on UCP3 protein expression in human vastus lateralis muscle.
Six healthy male lean subjects were successively fed equicaloric low fat (LF, 30 En% fat, 60 En% carbohydrates, 10 En% protein) and high fat (HF, 60 En% fat, 30 En% carbohydrates, 10 En% protein) diets. Both diets were consumed for 7 days and prepared as daily portions matching each estimated individual's food intake. After 7 days low-or high fat diet the subjects reported to the lab after an overnight fast. Muscle biopsies (m. vastus lateralis) and blood samples were taken. Data were studied by paired t-test (p`0.05) and presented as LF vs. HF (mean AE SD).
UCP3 protein expression (AU) was studied by densitometry after Western blotting and increased 1.4-fold (0.48 AE 0.14 vs. 0.69 AE 0.2, p 0.040). Plasma triglycerides (mmolal) INTRODUCTION: Recent data from our study conducted in Lublin Region suggest that the epidemic of obesity involved also the population of Eastern Poland. We assessed the prevalence of obesity at 40% of women and 20% of men in rural population and at 35% of women and 31% of men in urban population. The aim of this study was to evaluate the family history of obesity in three generations of index cases aged 35 years and more. METHODS: An analysis was performed in 1818 index cases living in countryside and in 2062 index cases from Lublin town (divided into obese, overweight and normalweight). We considered factors susceptible to modify the familial clustering of obesity (age of index cases, time of their obesity onset, the number of children, smoking habits, parameters of daily physical activity). This population is demographically well-de®ned but has different life styles depending on rural or urban background. We considered only people whose familial morbidity was known from their medical history.
RESULTS:
The frequencies of obese mothers of both index women and index men were alike. (1, 2) . The purpose of the present study was to investigate a possible relation between obesity and adenovirus infection in a group of normal-weight and overweight Danish subjects. METHODS: Fasting serum samples from a total of 70 overweight (BMI b 25 kgam 2 ) and 30 normal-weight subjects (BMI`25 kgam 2 ) were screened for antibodies against the Ad-36 adenovirus using a serum neutralization assay. Subsequently, overweight subjects were divided into an Ad-36 positive (n 4) and an Ad-36 negative group (n 63) and compared with regard to body weight, BMI, sagittal height, serum cholesterol, serum triacylglycerol and weight loss during a 50 week subsequent slimming course. RESULTS: A total of 5.7% (n 4) of the overweight subjects and 10.0% (n 3) of the normal-weight subjects were found to have antibodies against the Ad-36 virus (ns). Furthermore, we found no signi®cant differences between the two overweight groups concerning body weight, BMI, sagittal height, serum cholesterol, serum triacylglycerol and weight loss during a subsequent slimming course. CONCLUSION: Based on ®ndings in this subpopulation there is no evidence to support that infection by adenovirus-36 is an important cause of the increasing prevalence of obesity in Denmark. Several metabolic functions of adipose tissue (storage and mobilisation of lipids, hormonal secretion) are subject to change with adipocyte size. This phenomenon occurs during the development of obesity but could be also present in normal subject and within the same fat depot. We hypothesised that the increase in fat cell size, per se, could modulate several signalling pathways by changing the relationships between cell and extracellular matrix, andaor plasma membrane composition. We ®rst demonstrated that in rat adipocytes isolated from the same tissue (epididymal), adipocyte function depends on fat cell volume. We have therefore investigated in``large'' and``small'' adipocytes (52 and 22Â10 3 mm 3 , respectively): (i) both the quantity and the activity of ERK 1,2 (MAP Kinases involved in the transduction pathway which follows the activation of integrin receptors), (ii) the cholesterol concentration of membrane fraction (cholesterol could be a sensor of adipocyte hypertrophy*). In large compared with small adipocytes, cytoplasmic concentrations of ERK 1,2 (Western blotting) were two fold increased whereas the activity was multiplied by 10. In membrane fraction, cholesterol could be detected only as free cholesterol, the concentration of which was decreased by 50% in large compared to small adipocytes.
In conclusion: 1 ± activation of the MAP Kinase signal transduction pathway (as the result of integrin signalling?) occurs when fat cell volume increases, suggesting that ERKs (which activate a number of transcription factors) could be important factors in the adaptation of adipose function to cell size.
2 ± adipocyte hypertrophy is associated with a reduced membrane cholesterol content, suggesting that cholesterol concentration is an indicator of the repletion state of the cell and could subsequently modulate (via the transcription factor SREBP2) many genes expression. * Boizard M et al (1998) 
University of Maastricht, The Netherlands
The combined adipose tissues form an important metabolic organ, which plays an important role in the development of chronic diseases such as obesitas. However different depots are differently associated with risk. We would like to obtain a better understanding of the physiology of the different adipose depots. For this DNA microarray technology is used. This is a powerful technology to study the expression of a large number of genes at the same time and it is therefore suitable to identify genes that differ in expression between different depots.
To identify genes that are differentially regulated in adipocyte differentiation, a fat array was constructed consisting of approximately 350 known sequences and 1800 unknown sequences speci®c for white adipose tissue. The unknown sequences were obtained by subtractive hybridisation using RNA from subcutaneous white adipose tissue samples. mRNA was isolated from different human fat depots and the intra-individual expression was compared using the constructed array. Our ®rst results will be presented. 
INTRODUCTION:
A polymorphism in codon 363 of the glucocorticoid receptor (GR) gene seems to be associated with increased sensitivity to glucocorticoids. In a previous study (Huizenga et al 1998) , individuals carrying this polymorphism seemed healthy at clinical examination but had a higher sensitivity to exogenously administered glucocorticoids, and an increased Body Mass Index (BMI). This study investigated the frequency of this variant in Brazilian population with different grades of obesity. METHODS: We studied a total of 424 individuals from Brazil. Fifty-seven with normal BMI, mean age 27.3 AE 5.4 years. The others 367 were obese with ages from 17 to 73 years, 87.2% female and 12.8% male, with different grades of obesity according BMI: grade 1 (BMI 30 ± 34.9 kgam 2 , n 101), grade 2 (BMI 35 ± 39.9 kgam 2 , n 72) and grade 3 (BMI b 40 Kgam 2 , n 194). All participants were genotyped by Restriction Fragment Length Polymorphism (RFLP) analysis. RESULTS: The overall frequency of Ser363 was 1.9%. The mutation was found to be heterozygous in all cases. The frequency according BMI was 1% to grade 1, 4.2% and 1% to grade 2 and 3 respectively. People with normal weight had a frequency of 3.5%. CONCLUSION: We found that a polymorphism in codon 363 of glucocorticoid receptor gene was not frequent in our population and it wasn't associated with increasing grades of obesity.
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Effect of conjugated linoleic acid (CLA) isomers on thermogenic capacity in primary cultured brown adipocytes Conjugated Linoleic Acid (CLA) isomers are a group of positional and geometric conjugated diene isomers of linoleic acid (LA) that appear at high concentrations in meat and dairy products from rumiants. Dietary CLA supplementation has been described to reduce body fat content and body weight in rodents, associated with an increase in total energy expenditure without affecting food intake. In fact, different studies with cultured white adipocytes treated with CLA isomers reported a decreased lipid accumulation and an increased lipid metabolism. Brown Adipose Tissue (BAT) plays an important role in whole body energy expenditure, with particular relevance in small mammals. BAT thermogenesis is highly dependent on the activity of uncoupling protein 1 (UCP1), an inner mitochondrial membrane protein which can dissipate energy as heat by uncoupling oxidative phosphorilation. In addition, other proteins with a potential uncoupling activity, UCP2 and UCP3, have also been identi®ed. The main regulator of BAT thermogenesis is noradrenaline (NA) via adrenergic receptors (AR).
The aim of the present study was to look at the response of some genes involved in thermogenesis, such as UCP1, UCP2 and b3-AR, to CLA isomers in cultured brown preadipocytes from mice with and without NA-stimulation (by Northern and Western blot). Protein and lipid levels and cytochrome c oxidase (COx) activity have also been measured.
A tendency to increase triacylglyceride content and COx activity in response to fatty acid treatment (CLA isomers and LA) have been observed. Treatment with the trans-10, cis-12 CLA leads to a characteristic pattern of lipid droplet ®lling. The induction of UCP1 (mRNA and protein levels) by NA was inhibited by the presence of trans-10, cis-12 CLA. This effect was dosedependent and was different from those observed in the presence of LA or cis-9, trans-11 CLA. b3-AR expression tended to decrease after CLA treatment, the effect being more important in NA-stimulated adipocytes and trans-10, cis-12 CLA treatment. No changes in UCP2 mRNA levels related to any treatment were observed. In conclusion, CLA isomers, and especially the trans-10, cis-12 CLA isomer, show an alteration in the activation of key thermogenic parameters and the lipid accumulation of cultured brown adipocytes. The PPARg (peroxisome proliferator-activated receptor g) is a transcription factor pertaining to the hormonal nuclear receptor family which is involved in the regulation of adipocyte differentiation, lipidic metabolism and glucose homeostasis. Previous studies have associated the Pro12Ala variant to an increase in sensitivity to insulin, and to the BMI (body mass index). Moreover, the TNFa (tumour necrosis factor a) inhibits adipocyte differentiation, and is involved in insulin resistance induction. The 7308G?A polymorphism in the TNFa gene has been associated with a greater rate of transcription of the gene, although up to now it has not been possible to demonstrate its association with the metabolic syndrome.
The aim of this study has been to determine whether there exists an association between parameters which are markers of medical complications of obesity and two polymorphisms: 7308G?A of the TNFa gene and Pro12Ala of the PPARg gene, as well as to analyse whether the combination of both alleles has an additive effect on these parameters.
We have studied a group of obese women from Mallorca (Spain) (BMI ! 30, n 47) and we have registered anthropometric and clinical parameters. The genotype for both polymorphisms was determined by RFLP-PCR (restriction fragment length polymorphism-polymerase chain reaction) in agreement with protocols previously described.
Our results indicate an association between the Ala12 allele and a greater hip diameter, and between the 7308A allele and higher systolic blood pressure values. The 7308A allele also appears to be related to higher plasma glucose levels, which would be in agreement with a role of the TNFa in insulin resistance, a role which would be reinforced by the greater rate of transcription attributed to the polymorphism. In addition, our results suggest that the Ala12 allele would have a protective effect on the increase of glucose levels associated to the 7308A allele.
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Polymorphisms in three obesity related genes in Koreans Obesity results from the combined effects of genetic and nongenetic factors. Genetic factors might in¯uence appetite, regulate food intake and metabolism through many pathways. Most of the previous studies for several polymorphism of obesity candidate genes were different from population of ethinity. Therefore, we investigated association of three polymorphisms of obesity related genes and obesity association among three polymorphism in Korean.
MATERIALS AND METHODS:
The study groups consisted to 93 obese subjects (BMI ! 30 kgam 2 ) and 99 nonobese subjects (BMI 18.5 ± 24.9 kgam 2 ) from Obesity Clinic in Keimyung University Dongsan Medical Center in Taegu, Korea. Serum lipid and blood glucose were measured by an autoanalyzer. Obesity phenotypes were BMI, WHR, visceral fat amount, and total fat percent. Genotyping of the Pro12Ala in the PPARg gene, Gln223Arg in the Leptin receptor genes, and Trp64Arg in the b3-adrenergic receptor genes were processed by protocol. RESULTS: Allele frequencies for Ala223 in the Leptin receptor gene between nonobese and obese group was signi®cantly different (p 0.033). There were no difference in the Arg64 allele frequency of the b3-AR and Ala12 allele frequency of the PPARg between both groups. After adjustment for age, sex and BMI, signi®cant difference were found in total body fat %, and atherogenic index between mutant homozygote and heterozygote of Gln223Ala, BMI between wild type and heterozygote of the Pro12Ala in obese group. Atherogenic index in obese group was signi®cantly higher subjects with more associated variants than subjects with less associated variants for both Gln223Ala in Leptin receptor gene and Pro12Ala of the PPARg gene. Visceral fat amount in obese group and LDL-cholesterol in nonobese group were signi®cant greater among the subjects with more associated both polymorphisms than among those with less associated both polymorphisms between Gln223Ala in the Leptin receptor gene and Trp64Arg in the b3-AR. CONCLUSIONS: This study suggested that association of the Gln223Ala in the Leptin receptor gene, Pro12Ala in the PPARg gene, Trp64Arg in the b3-AR gene have synergistic effect for contributing to body fat distribution and serum lipid in Korean. In accordance with the foetal origins hypothesis these characteristics indicate greater adult risk of obesity related diseases. The prevalence of catch-up growth increases with low birthweight. Infants in developing countries experiencing`nutritional transition' have relatively low birthweights and post-natal exposure to`western diets'. It is not known whether these factors combine to increase the prevalence of catch-up growth and thus lead to an increased risk of obesity in children from developing countries. This investigation sought to ®nd the prevalence of catch-upadown growth by two years of age and relate it to growth and body composition up to 7 years of age in a mixed-longitudinal cohort of children from Soweto, South Africa.
METHODS:
The sample for analysis was composed of 362 black children (191 boys) of normal gestational ages (36 ± 40 weeks). Data for analysis included birthweight and lengthaheight, weight, triceps and subscapular skinfolds and body mass index (BMI) at 1, 2, 4, 5, and 7 years of age. Catch-upadown growth was de®ned as a 0.67 change in Z-score between birth and 2 years. RESULTS: Clinically signi®cant catch-up growth was found in 23% (n 82) of the sample and catch-down in 40% (n 145). There were no signi®cant differences in any maternal characteristics (age, SES, height, weight) between catch-up, catch-down or normal groups. Catch-up children were signi®cantly lighter at birth but by one year of age were signi®cantly taller, heavier and fatter, with greater BMIs than either catch-down or normal groups. These characteristics persisted throughout the 7 years of the study. CONCLUSION: The 23% of urban children in Soweto, South Africa who exhibit catch-up growth have relatively low birthweights and also have signi®cantly increased risk factors for later obesity by one year of age.
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Taq-I alleles of dopamine receptor gene in obese families from South Poland 
INTRODUCTION:
The mesocorticolimbic dopaminergic reward pathways have a role in the neuromodulation of appetite. There are data supporting a role of allelic variants of D2 dopamine receptor (DRD2) gene and the number of receptor binding sites in vulnerability to drug abuse and obesity. METHODS: The prevalence of Taql A D2 dopamine receptor (DRD2) alleles were determined in 68 women and men from obese families from South Poland by PCR-RLFP. RESULTS: The mean body mass index of study group was 33.2 kgam 2 . The DRD2-TaqI() allele was present in 76% of this nonalcohol, nondrug-abusing subjects. The DRD2-TaqI() allele was not associated with a number of cardiovascular risk factors examined, including blood lipids (cholesterol, high-density lipoprotein [HDL]-and low-density lipoprotein [LDL]-cholesterol, and triglycerides). However, phenotypic factors characterised by the presence of parental history and post-puberty onset of obesity as well as carbohydrate preference were associated with subjects carrying the DRD2-TaqI() allele. The cumulative number of these three factors was positively and signi®cantly related to DRD2-TaqI() allelic prevalence. CONCLUSION: The data showing an association of the () allele of the DRD2 gene with phenotypic characteristics suggest that this gene, located on q22 ± q23 region of chromosome 11, confers susceptibility to development of obesity. Hypoxia-induced changes in metabolism and gene expression are related to decreased intracellular cAMP levels. Moreover, previous study have reported that hypoxia impairs adipocyte differentiation 1 . In adipocytes, cAMP levels can be modulated by numerous factors among which catecholamines and insulin play a central role. Stimulation of a 2 -adrenergic and insulin receptors decrease intracellular cAMP levels, and b-adrenergic stimulation increased cAMP. The aim of this work was to investigate the effects of hypoxia on gene expression in mature adipocyte and their modulation by catecholamines and insulin.
For this study, human adipose tissue explants was cultured with various pharmacological agents, and adipocyte gene expression was assessed by Northern blot and RT-PCR.
We observed that human adipose tissue culture triggered adipocytes in hypoxic state assessed by increasing glucose consumption and lactate production, associated with an increase in hypoxia-related gene expression (i.e. GLUT1, TNF-a). In parallel, we observed a decrease in adipocyte gene expression (i.e. aP2, HSL, LPL, PPARg2). This gene regulation was dependent of intracellular cAMP levels since increased (by b-adrenergic agonist and methylisobutylxanthine) or decreased (by a 2 -adrenergic agonist and insulin) cAMP respectively conteracted and enhanced hypoxia deleterous effect on adipocyte gene expression. Similar results were obtained in 3T3F442A adipocytes where hypoxia was mimicked by cobalt chloride treatment.
Genetic variants of the lipoprotein lipase, apolipoprotein E and CIII genes have been suggested to be associated with dyslipidemia, insulin resistance, obesity and coronary artery disease. METHODS: In our study we evaluated the in¯uence of the common lipase lipoprotein LPL-H (HindIII), LPL-P (Pvu II), apolipoprotein CIII (ApoCIII-SstI) polymorphisms (RFLP), and the genotypes of apolipoprotein E (ApoE) on lipid and carbohydrate metabolism in the 14 obese families of South Poland (59 participants). RESULTS: The allele frequencies for LPL-H(), LPL-P() and ApoCIII-SstI() were 0.64; 0.49 and 0.08 and respectively. The frequencies of apoE alelle e4, e3 and e2 were 0.17, 0.75 and 0.08, respectively and do not distinguish our group from other European populations. The distributions of () alleles for lipoprotein lipase (both polymorphic sites) were signi®cantly lower in the group of massively obese subjects (BMI b 35). An association between BMI, lipid, lipoprotein and glucose metabolism between carriers and no carriers of both lipoprotein lipase polymorphic sites was observed. Comparing with genotypes LPL-H(7a7) and LPL-P(7a7) the LPL-H( a ) and LPL-P( a ) carriers demonstrated the higher total fasting and postprandial lipaemia, higher total and LDL cholesterol, and decreased HDL concentration. LPL-H(7) and LPL-P(7) allele carriers demonstrated symptoms of insulin resistance (shape of insulin curve after OGTT), and endothelial dysfunction evidenced by increased von Willebrand factor (vWF), which occurs more frequently in those groups. But any signi®cant difference in the glucose tolerance and insulin output in above groups was observed. However the isolated LPL-P( 7 a 7 ) and LPL-H( 7 a 7 ) genotype carriers demonstrated the more impaired tolerance of glucose and increase insulin output. This group of individuals represented the highest BMI values among all investigated groups. Patients LPL-H( 7 a 7 ) have the statistically signi®cant higher body mass index (BMI) in comparison to LPL-H( a ) genotypes group. The only 5 heterozygote carriers with apoCIII-SstI was found, but they demonstrated high BMI, signi®cantly impaired Tg but not glucose tolerance. There were no signi®cant differences between genotype Apo E and all investigated biochemical variables. The group of e2 allele carriers had signi®cantly higher BMI values. There were no statistical association between all polymorphism studied and the fasting blood leptin. CONCLUSION: Our studies add some more information about the obesity, lipid and carbohydrate metabolism disturbances, which are associated with common LPL-P, LPL-H, apo CIII-SstI and apoE genes polymorphism. However the effect on the cardiovascular risk needs further investigations.
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Skeletal muscle heterogeneity in fasting-induced upregulation of genes encoding uncoupling protein homologues UCP2, UCP3 and key regulators of lipid oxidation S Samec 1 , J Seydoux 1 , and AG Dulloo
